Conclusion. About one in 11 admissions with UTI are ESBL + /FQ NS and are more likely to be male, with HCA risk factors and other important comorbidities. Current oral antibiotic therapy is limited in such episodes and oral treatment alternatives are needed. Results. A total of 369 patients were included; 40.4% had EAB and 6% had a UTI in the EPT (eUTI). rUTI occurred in 5.7% of patients (n = 21). In the rUTI group, 8 (38.1%) had EAB, 8 (38.1%) had eUTI, and 5 (23.8%) had neither (P = 0.067). rUTI developed in 5.3% (8/149) of the EAB group vs. 36.4% (8/22) of the eUTI group (P < 0.005). No other variables were associated with rUTI. Total UTI episodes was greater with eUTI than EAB (mean 2.09 vs. 0.28, 95% CI 2.2-1.4, P < 0.005).
Background. The optimal antibiotic (ABX) treatment duration for uncomplicated urinary tract infection (UTI) in pediatric patients is unknown. The objective of this study was to investigate the association of pediatric UTI treatment duration (7, 10, or 14 days) with infection recurrence or progression.
Methods. A retrospective cohort analysis of pediatric patients aged 2-17 years with first cystitis or pyelonephritis and without renal/anatomic abnormality was performed using claims and eligibility data from Truven Health MarketScan Database for [2013] [2014] [2015] . Parenteral ABX use and treatment of cystitis diagnosis only were covariates. Relapse and reinfection were defined a priori as UTI diagnosed from, respectively, 0-14 days and 15-30 days following ABX depletion; recurrence was defined as either relapse or reinfection. Progressing infection was defined as recurrence diagnosis of pyelonephritis in a patient originally diagnosed with cystitis only.
Results. Of 7,698 pediatric patients (43.8% aged 2-10 years; 56.2% aged 11-17 years), 85.5% had cystitis and 14.3% pyelonephritis. Duration of ABX treatment included: 3-5 days for cystitis only (20.4%), or 7 (33.6%), 10 (44.2%), or 14 (1.8%) days for any UTI. Recurrence and progressing infection occurred in 5.5% and 0.2% of patients, respectively. Covariates associated with increased recurrence risk included pre-treatment ABX exposure (OR = 1.29; 95% CI = 1.06-1.57); pyelonephritis on diagnosis date (OR = 1.44; 95% CI = 1.03-2.00); follow-up visit during ABX treatment (OR = 3.21; 95% CI = 2.20-4.68); parenteral ABX (OR = 1.89, 95% CI = 1.33-2.69); use of nitrofurantoin (NFT) only (OR = 1.34, 95% CI = 1.00-1.92); and interaction of NFT with pyelonephritis diagnosis (OR = 3.68, 95% CI = 1.20-11.29). After adjustment for measured confounders, the association between duration of ABX treatment and recurrence was not significant (compared with 7 days, 10 days: OR = 1.07, 95% CI = 0.85-1.33; compared with 7 days, 14 days: OR = 0.89, 95% CI 0.45-1.78).
Conclusion. In a national cohort of pediatric patients with uncomplicated UTI, rates of recurrence after ABX depletion did not significantly differ among treatment durations of 7, 10, and 14 days. Results provide support for, without definitively establishing efficacy of, shorter-course ABX treatment.
Disclosures. All authors: No reported disclosures. Background. The ED environment makes proactive collection of urine cultures (UCs) favorable. However, unnecessary UCs can result in over-detection and over-treatment of asymptomatic bacteriuria (ASB). A previous analysis at the study facility found that UCs were collected frequently despite negative urinalyses (UA), which commonly resulted in unnecessary antibiotics. Our objective was to compare the frequency of inappropriate UC utilization and inappropriate antibiotic prescribing post implementation of a "Urinalysis to Reflex Culture" process change intervention. A secondary objective was to assess the frequency of health encounters for UTIs post implementation.
Evaluating the Effects of a "Urinalysis to
Methods. After education, an ED process change was implemented in October 2017. This included automatic UC cancellation if UAs had <5 WBC/HPF. An option for "do not cancel (DNC)" UC was available for specific conditions (eg. pregnancy) per guidelines. Data were prospectively collected for 3 months post-implementation and included UA/UC results, presence of UTI symptoms, antibiotics prescribed and healthcare utilization. Inappropriate UC was defined as a UC ordered despite negative UA in asymptomatic patients. Inappropriate antibiotic prescribing was defined as treatment in patients with ASB. A Student's t-test and contingency tables were applied in SAS; significance was set at P ≤ 0.05.
Results. There were 684 UAs (37.2% post-intervention) evaluated from ED visits. Post-intervention (n = 255 UAs), 37.3% of UAs were negative with UCs cancelled. Of the remaining UAs, 37.3% were positive with a processed UC, 16.9% were ordered as DNC and 8.6% were ordered without a UC. UC processing despite a negative UA significantly decreased from 100% pre-intervention to 38.6% post-intervention (P < 0.001). Inappropriate antibiotics for ASB also decreased from 10.2% pre-intervention to 1.9% post-intervention (OR = 0.17; P < 0.0110). In patients with negative UAs, antibiotic prescribing decreased by 25.3% post-intervention (P = NS). No reports of outpatient, ED, or hospital visits for UTI symptoms were found within 7 days of initial UA post-intervention.
Conclusion.
A "UA to Reflex Culture" process change demonstrated a significant decrease in processing of inappropriate UCs and unnecessary antibiotics for ASB. There were no missed UTIs or other adverse patient outcomes.
Disclosures. All authors: No reported disclosures. and was treated 74.6% of the time (Figure 3 ). Significant risk factors for MDR UTI included female gender (P = 0.005), IV abx (P = 0.001), and recurrent UTI (P = 0.017). Conclusion. Incidence of symptomatic UTI at our center was lower than previous reports. E. coli and E. faecalis were the most common urinary pathogens identified. MDR risk factors identified were biologically plausible and consistent with prior literature. ASB treatment occurred frequently and is an area to target stewardship interventions. Background. The clinical significance of Staphylococcus aureus bacteriuria (SABU) is unclear and often presumed to represent hematogenous spread of occult S. aureus bacteremia (SAB). The aim of this study was to evaluate the clinical significance of SABU by assessing factors associated with the development of invasive S. aureus disease and 12-month mortality. We also describe the proportion of patients with methicillin-resistant S. aureus (MRSA), symptomatic urinary tract infection (UTI), asymptomatic bacteriuria, concomitant SAB, and calculate Charlson comorbidity scores.
Urinary Tract Infections (UTIs) in the First
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Clinical Significance of Staphylococcus aureus
Methods. This is a retrospective cohort study of all SABU isolates in a tertiary care hospital from 1 January 2007 to 31 December 2016. Cases were identified by screening specimens processed in the microbiology laboratory with records in the Phoenix/BG data system. Demographic data, Charlson comorbidity score, antimicrobial susceptibility profiles, urinary catheter use, residence in a long-term care facility, and UTI symptoms were obtained through chart review.
Results. A total of 356 patients with SABU were identified and 237 met inclusion criteria. Seventeen patients had concurrent invasive S. aureus infections and 220 patients had SABU without invasive infection or SAB. Of the 220 patients with SABU and no invasive S. aureus infection, none developed invasive disease. The 12-month mortality rate was 6.8% in those without concurrent SAB and 52.9% in those with invasive infection. In those without concurrent invasive S. aureus infection, male sex (P = 0.033), MRSA (P = 0.008), collection of blood cultures (P = 0.005), and Charlson comorbidity score (P ≤ 0.001) were identified as risk factors for 12-month mortality. Race, inpatient status, specimen type, pyuria, UTI symptoms, and urologic instrumentation were not significantly associated with mortality.
Conclusion. Patients without evident invasive S. aureus infection at the time of urine culture were not observed to present with invasive disease in the following year. Mortality increases with Charlson score and invasive infection in patients with SABU. Clinicians may consider isolated UTI, contamination, and colonization before embarking on extensive searches for occult staphylococcal infection in patients who present without obvious invasive infection, particularly in those without comorbid disease.
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